ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,212.20
0.10%
S&P ASX All Technology
3,444.90
0.35%
Brent Oil
71.375
0.60%
US Dollar vs AUD
1.44817
-0.19%
Bitcoin
66,176.32
1.52%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Allergy Therapeutics Plc (AGY)

  7. Allergy Therapeutics Plc (AGY) News

AGY

Allergy Therapeutics (AGY)

Allergy Therapeutics Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:AGY
DateTimeSourceHeadlineSymbolCompany
17/09/202416:00RNS Regulatory NewsAllergy Therapeutics PLC Progression of patient cohorts in PROTECT TrialLSE:AGYAllergy Therapeutics Plc
27/08/202418:57Alliance NewsAlliance NewsAllergy Therapeutics secures cash to see it through SeptemberLSE:AGYAllergy Therapeutics Plc
27/08/202416:00RNS Regulatory NewsAllergy Therapeutics PLC Update on fundingLSE:AGYAllergy Therapeutics Plc
23/07/202401:26Alliance NewsAlliance NewsTRADING UPDATES: Croma Security trading well; Fonix to up final payoutLSE:AGYAllergy Therapeutics Plc
22/07/202416:01RNS Regulatory NewsAllergy Therapeutics PLC Trading update for the year ended 30 June 2024LSE:AGYAllergy Therapeutics Plc
22/07/202416:00RNS Regulatory NewsAllergy Therapeutics PLC Appointment of Nominated Adviser and Sole BrokerLSE:AGYAllergy Therapeutics Plc
04/07/202423:22RNS Regulatory NewsAllergy Therapeutics PLC Launch of new Company Long Term Incentive PlanLSE:AGYAllergy Therapeutics Plc
27/06/202416:00RNS Regulatory NewsAllergy Therapeutics PLC Appointment of Non-Executive DirectorLSE:AGYAllergy Therapeutics Plc
10/06/202418:36Alliance NewsAlliance NewsAllergy Therapeutics welcomes peanut allergy vaccine trial resultsLSE:AGYAllergy Therapeutics Plc
10/06/202416:00RNS Regulatory NewsAllergy Therapeutics PLC Progression of patient cohorts in PROTECT TrialLSE:AGYAllergy Therapeutics Plc
03/06/202416:00RNS Regulatory NewsAllergy Therapeutics PLC Successful meetings with Paul Ehrlich InstitutLSE:AGYAllergy Therapeutics Plc
31/05/202416:00RNS Non-RegulatoryAllergy Therapeutics PLC Allergy Therapeutics presents findings at EAACILSE:AGYAllergy Therapeutics Plc
08/05/202405:22Alliance NewsAlliance NewsTRADING UPDATES: Abingdon Health buys IVDeology HoldingsLSE:AGYAllergy Therapeutics Plc
07/05/202416:00RNS Regulatory NewsAllergy Therapeutics PLC Further detail from G306 Phase III field trialLSE:AGYAllergy Therapeutics Plc
03/04/202417:00RNS Regulatory NewsAllergy Therapeutics PLC Director ResignationLSE:AGYAllergy Therapeutics Plc
28/03/202403:13Alliance NewsAlliance NewsEARNINGS AND TRADING: Solid State ups outlook; Quartix trading in lineLSE:AGYAllergy Therapeutics Plc
27/03/202418:00RNS Regulatory NewsAllergy Therapeutics PLC Update on fundingLSE:AGYAllergy Therapeutics Plc
27/03/202418:00RNS Regulatory NewsAllergy Therapeutics PLC Interim Results for six months ended 31 Dec 2023LSE:AGYAllergy Therapeutics Plc
13/03/202401:06Alliance NewsAlliance NewsAllergy Therapeutics starts dosing patients in peanut allergy trialLSE:AGYAllergy Therapeutics Plc
12/03/202419:59RNS Regulatory NewsAllergy Therapeutics PLC VLP Peanut PROTECT Trial UpdateLSE:AGYAllergy Therapeutics Plc
12/03/202418:00RNS Non-RegulatoryAllergy Therapeutics PLC VLP Peanut PROTECT Trial UpdateLSE:AGYAllergy Therapeutics Plc
11/03/202418:00RNS Regulatory NewsAllergy Therapeutics PLC Appointment of Shaun Furlong to Board of DirectorsLSE:AGYAllergy Therapeutics Plc
09/03/202400:49RNS Regulatory NewsAllergy Therapeutics PLC Result of AGMLSE:AGYAllergy Therapeutics Plc
14/02/202421:22Alliance NewsAlliance NewsAllergy Therapeutics forecasts revenue drop but trials going wellLSE:AGYAllergy Therapeutics Plc
14/02/202418:00RNS Regulatory NewsAllergy Therapeutics PLC Half-Year Trading Update 2024LSE:AGYAllergy Therapeutics Plc
10/02/202402:07RNS Regulatory NewsAllergy Therapeutics PLC Notice of 2023 Annual General MeetingLSE:AGYAllergy Therapeutics Plc
30/01/202421:38Alliance NewsAlliance NewsAllergy Therapeutics resumes trading on AIM; annual revenue plungesLSE:AGYAllergy Therapeutics Plc
30/01/202418:30RNS Regulatory NewsAIM Restoration - Allergy Therapeutics plcLSE:AGYAllergy Therapeutics Plc
30/01/202418:00RNS Regulatory NewsAllergy Therapeutics PLC Publication of Annual Report and Accounts 2023LSE:AGYAllergy Therapeutics Plc
04/01/202423:29UK RegulatoryAllergy Therapeutics PLC Total Voting RightsLSE:AGYAllergy Therapeutics Plc
 Showing the most relevant articles for your search:LSE:AGY

Your Recent History

NASDAQ
ABBABXX
Morgan Stanley Finance L...
BIT
UI226B
Unicredit Bank
BIT
P1V2T2
NLBNPIT1V2T2 20991231 22...
TG
BVXB
Itau Unibanco SA Grand C...
NASDAQI
HUR
ISE Cyber Security UCITS
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved